The Antiphospholipid Syndrome II (eBook, PDF)

Autoimmune Thrombosis
Redaktion: Cervera, R.; Shoenfeld, Yehuda; Piette, J. C.

• Format: PDF

Produktbeschreibung

This book provides the reader with a comprehensive overview of the Antiphospholipid syndrome. One of the most important advances in rheumatology and connective tissue diseases of the last decade. It provides an explanation for many previously undefined conditions with no clear pathogenesis encompassing all subspeculations in internal medicine as well as obstetrics. Clotting problems leading to strokes and myocardial infarctions (in younger people) as well as a large variety of other syndromes such as chorea, hyproadrenalism, pulmonary problems are now being understood.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 478
• Erscheinungstermin: 22. August 2002
• Englisch
• ISBN-13: 9780080527307
• Artikelnr.: 38119984

Inhaltsangabe

Preface. Editor biography. List of Contributors. I. History and
Epidemiology of the Antiphospholipid Syndrome (R.A. Asherson). Milestones
in the Antiphospholipid Syndrome (R.A. Asherson et al.). Classification and
Epidemiology of the Antiphospholipid Syndrome (M. Petri). II. Immunology
and Pathophysiology of the Antiphospholipid Syndrome (Y. Shoenfeld). Lupus
Anticoagulant: Detection, Standardization and Heterogeneity (D.A. Triplett,
M.-C. Boffa). Antibodies to Cardiolipin and other Phospholipids (S.S.
Pierangeli, E.N. Harris). &bgr;-Glycoprotein I and anti-&bgr;-Glycoprotein
I Antibodies (P.G. De Groot et al.). Anti-Prothrombin Antibodies (M.
Galli). The Annexins: A Target of Antiphospholipid Antibodies (J.H. Rand,
Xiao-Xuan Wu). Antiphospholipid/Endothelial Cell Interaction in the
Pathogenesis of the Antiphospholipid Syndrome (P.L. Luigi et al.). Tissue
Factor, Protein C pathway and other Hemostasis Abnormalities in the
Pathogenesis of the Antiphospholipid Syndrome (R.A.S. Roubey). Systemic
Involvement in the Antiphospholipid Syndrome: Lessons from Animal Models
(Y. Shoenfeld et al.). Cytokines, Th1/Th2 and Adhesion Molecules in the
Antiphospholipid Syndrome (M. Ehrenfeld et al.). Lessons from Monoclonal
Antiphospholipid Antibodies (M. Abu-Shakra, Y. Shoenfeld). Immunogenetics
of the Antiphospholipid Syndrome (G.D. Sebastiani et al.). Pathology of the
Antiphospholipid Syndrome (E. Reyes, D. Alarcón-Segovia). Antiphospholipid
Antibodies in Human and Murine Atherogenesis (Y. Sherer, Y. Shoenfeld).
III. Clinical Features in the Antiphospholipid Syndrome (R. Cervera).
Thrombotic Manifestations in the Antiphospholipid Syndrome (J.O. Ros et al.
). Neurologic Manifestations in the Antiphospholipid Syndrome (R.L. Brey
et al.). Cardiac and Pulmonary Manifestations in the Antiphospholipid
Syndrome (G. Espinosa et al.). Renal, Hepatic and other Intra-abdominal
Manifestations in the Antiphospholipid Syndrome (P. von Landenberg et al.
). Fetal and Obstetric Manifestations and Infertility in the
Antiphospholipid Syndrome (F. Carmona, J. Balasch). Osteo articular
Manifestations in the Antiphospholipid Syndrome (F. Lioté, O. Meyer).
Ophthalmic and Otological Manifestations in the Antiphospholipid Syndrome
(A. Montehermoso et al.). Dermatologic Manifestations in the
Antiphospholipid Syndrome (C. Frances, J.C. Piette). Endocrine
Manifestations in the Antiphospholipid Syndrome (R.A. Asherson, M. Petri).
Hematological Abnormalities in the Antiphospholipid Syndrome (G. Espinosa
et al.). Immunological Abnormalities in the Antiphospholipid Syndrome (A.
Tincani et al.). ''Primary'', ''Secondary'', ''Seronegative'',
''Catastrophic'' and other Subsets of the Antiphospholipid Syndrome (R.A.
Asherson et al.). Pediatric and Familial Antiphospholipid Syndrome (L.R.
Sammaritano, J.-C. Piette). Antiphospholipid Antibodies and Malignancies
(R.A. Asherson et al.). Antiphospholipid Antibodies and Vasculitis (R.A.
Asherson, R.A. Levy). Antiphospholipid Antibodies and Infections-Drugs (G.
Zandman-Goddard et al.). IV. Management and Prognosis of the
Antiphospholipid Syndrome (J.-C. Piette).
Management of Thrombosis in the Antiphospholipid Syndrome (R.H.W.M. Derksen
et al.). Management of Reproductive Failure in the Antiphospholipid
Syndrome (J. Balasch et al.). Management of the Difficult Aspects of the
Antiphospholipid Syndrome (D. Erkan et al.). Course and Prognosis of the
Antiphospholipid Syndrome (C. Drenkard, D. Alarcón-Segovia). Novel
Perspectives in the Treatment of the Antiphospholipid Syndrome - from
Anticoagulation to Immunomodulation (M. Blank et al.). V. Appendix.
The Antiphospholipid Syndrome in the Internet (M. Ramos-Casals, R.
Cervera). A Patient¿s Guide to the Antiphospholipid Syndrome (J. Berman et
al.). Subject Index.